Concepedia

Mariko Ishibashi

MI

Statistics

Publications

16

Citations

897

H-Index

15

Active since

1972

Affiliations

Nippon Medical School(Current)

Nihon University

Tokyo Women's Medical University

University of Tokyo Hospital

Daito Bunka University

Mariko Ishibashi is an author at Nippon Medical School specializing in medicine, oncology, and molecular oncology.

Publications per year

1972–2024

16

Publications

16

Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma

Hideto Tamura, Mariko Ishibashi, Takashi Yamashita et al. · Leukemia · 2012 · 226 citations

Medicine, Cancer Biology, Oncology +14

KRAS or BRAF mutation status is a useful predictor of sensitivity to MEK inhibition in ovarian cancer

Naomi Nakayama, Kentaro Nakayama, Sabina Yeasmin et al. · British Journal of Cancer · 2008 · 114 citations · Full text

Medicine, Gynecology, Oncology +17

Myeloma Drug Resistance Induced by Binding of Myeloma B7-H1 (PD-L1) to PD-1

Mariko Ishibashi, Hideto Tamura, Mika Sunakawa et al. · Cancer Immunology Research · 2016 · 95 citations

Medicine, Oncology, Pharmacology +17

Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes

Toshio Asayama, Hideto Tamura, Mariko Ishibashi et al. · Oncotarget · 2017 · 73 citations · Full text

Medicine, Hematology, Immunology +15

Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection

Mariko Esumi, Mariko Ishibashi, Hiromi Yamaguchi et al. · Hepatology · 2014 · 56 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17

1–5 of 16